A B56gamma mutation in lung cancer disrupts the p53-dependent tumor-suppressor function of protein phosphatase 2A

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Signaling

Background:

• B56gamma-specific protein phosphatase 2A (B56gamma-PP2A) exhibits both p53-dependent and -independent tumor-suppressive functions.
• The precise mechanisms underlying B56gamma-PP2A's tumor suppression, particularly in the absence of p53, remain largely unknown.
• While significant, no B56gamma mutations have been previously linked to human cancer.

Purpose of the Study:

• To differentiate between the p53-dependent and -independent functions of B56gamma-PP2A.
• To identify specific domains within B56gamma responsible for p53 interaction.
• To investigate the functional consequences of B56gamma mutations on p53-dependent tumor suppression.

Main Methods:

• Identification of the B56gamma domain crucial for p53 interaction.
• Characterization of a specific B56gamma mutation (F395C) found in lung cancer.
• Assays to evaluate the impact of the F395C mutation on p53 Thr55 dephosphorylation, p21 activation, and tumor suppression.

Main Results:

• A specific domain within B56gamma was identified as essential for p53 interaction.
• The lung cancer-associated mutation F395C was found to disrupt the B56gamma-p53 interaction.
• The F395C mutation abrogated B56gamma-PP2A's ability to dephosphorylate p53 at Thr55 and activate p21, thereby abolishing its p53-dependent tumor-suppressive activity.

Conclusions:

• This study elucidates the mechanistic basis for the distinct p53-dependent and -independent functions of B56gamma-PP2A.
• The findings establish a direct link between B56gamma-PP2A's p53-dependent tumor-suppressive function and tumorigenesis through the identified F395C mutation.
• B56gamma-PP2A's role in cancer development is highlighted, suggesting potential therapeutic targets.